Literature DB >> 19667991

Adherence to the medical regimen: clinical implications of new findings.

Janice Abbott1, Trudy Havermans, Anna Hart.   

Abstract

PURPOSE OF REVIEW: Treatment nonadherence is a common problem, yet adherence to treatments is important for the successful management of cystic fibrosis (CF). Previous work has concentrated on rates of adherence in children and adults using self-report questionnaires. Recent studies have employed new measurement methods and evaluated various treatment components. It is important to understand the factors that impede and facilitate adherence in order that research and clinical practice can improve adherence rates. RECENT
FINDINGS: There is a high perceived treatment burden in CF. Rates of adherence vary according to the treatment and the measurement method. Reasons for nonadherence are numerous. Even with technology designed to reduce treatment time, adherence to nebulized antibiotics is still poor. Nonadherence is a particular issue in adolescence and there is evidence that girls are less adherent than boys, leading to poorer lung function. Patients who have a cohesive and balanced family life may be better able to incorporate CF treatments. Treatment beliefs and the perception of treatment effectiveness are important determinants of adherence.
SUMMARY: Research needs to move forward to understand how to help patients to improve their adherence and to assist healthcare professionals in supporting them. There is a consensus that tailored interventions are essential. In addition, it is important to understand adherence behaviours over time in order to recognize specific periods during a person's life when adherence is more difficult to achieve.

Entities:  

Mesh:

Year:  2009        PMID: 19667991     DOI: 10.1097/MCP.0b013e3283310859

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  4 in total

1.  Parent-to-Child Transition in Managing Cystic Fibrosis: A Research Synthesis.

Authors:  Jennifer Leeman; Margarete Sandelowski; Nancy L Havill; Kathleen Knafl
Journal:  J Fam Theory Rev       Date:  2015-06

2.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

3.  Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: the EVOLVE trial.

Authors:  Michael W Konstan; David E Geller; Predrag Minić; Florian Brockhaus; Jie Zhang; Gerhild Angyalosi
Journal:  Pediatr Pulmonol       Date:  2010-10-20

4.  When Is Forgetting Not Forgetting? A Discursive Analysis of Differences in Forgetting Talk Between Adults With Cystic Fibrosis With Different Levels of Adherence to Nebulizer Treatments.

Authors:  Sarah J Drabble; Alicia O'Cathain; Madelynne A Arden; Marlene Hutchings; Daniel Beever; Martin Wildman
Journal:  Qual Health Res       Date:  2019-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.